By Sean Moloughney, Editor04.14.22
Cannabis has been held back by prohibition for decades, hamstringing research efforts and limiting consumer access. However, with market momentum building, science has been breaking through barriers to better explore potential applications in food/beverages, dietary supplements, pharmaceuticals, and more.
As a 501(c)(3) non-profit, Realm of Caring (RoC) is committed to research into novel healthcare options to improve quality of life and has served tens of thousands of families and healthcare professionals since its inception in 2013. Through research and education, RoC is facilitating the mainstream acceptance of cannabinoid-based therapies and building an empowered community.
“In partnership with Johns Hopkins University School of Medicine, our Observational Research Registry (ORR) is the largest cannabinoid therapy research program in the U.S.,” said Matthew Lowe, PhD, director of research at RoC. “The registry is an Institutional Review Boards-approved, longitudinal survey study examining the health effects of medicinal cannabis use, and it’s open to anyone in the world with internet
As a 501(c)(3) non-profit, Realm of Caring (RoC) is committed to research into novel healthcare options to improve quality of life and has served tens of thousands of families and healthcare professionals since its inception in 2013. Through research and education, RoC is facilitating the mainstream acceptance of cannabinoid-based therapies and building an empowered community.
“In partnership with Johns Hopkins University School of Medicine, our Observational Research Registry (ORR) is the largest cannabinoid therapy research program in the U.S.,” said Matthew Lowe, PhD, director of research at RoC. “The registry is an Institutional Review Boards-approved, longitudinal survey study examining the health effects of medicinal cannabis use, and it’s open to anyone in the world with internet
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
